The two-component regulatory system PhoP-PhoQ of Pseudomonas aeruginosa regulates resistance to cationic antimicrobial peptides, polymyxin B and aminoglycosides in response to low Mg 2+ + + + conditions. We have identified a second two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides. This system responds to limiting Mg 2 + , and is affected by a phoQ , but not a phoP mutation. Inactivation of the pmrB sensor kinase and pmrA response regulator greatly decreased the expression of the operon encoding pmrA-pmrB while expression of the response regulator pmrA in trans resulted in increased activation suggesting that the pmrA-pmrB operon is autoregulated. Interposon mutants in pmrB , pmrA , or in an intergenic region upstream of pmrApmrB exhibited two to 16-fold increased susceptibility to polymyxin B and cationic antimicrobial peptides. The pmrA-pmrB operon was also found to be activated by a number of cationic peptides including polymyxins B and E, cattle indolicidin and synthetic variants as well as LL-37, a component of human innate immunity, whereas peptides with the lowest minimum inhibitory concentrations tended to be the weakest inducers. Additionally, we showed that the putative LPS modification operon, PA3552-PA3559, was also induced by cationic peptides, but its expression was only partially dependent on the PmrA-PmrB system. The discovery that the PmrA-PmrB twocomponent system regulates resistance to cationic peptides and that both it and the putative LPS modification system are induced by cationic antimicrobial peptides has major implications for the development of these antibiotics as a therapy for P. aeruginosa infections.
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Introduction
Infections with Pseudomonas aeruginosa are particularly difficult to cure through antimicrobial therapy because of the bacterium's intrinsically impermeable outer membrane and active efflux of toxic agents from the cytoplasm (Nikaido, 1996) . Virtually no novel antibiotics are available for this organism although cationic antimicrobial peptides hold the promise of improving the success of antiPseudomonas therapy (Hancock, 1997) .
Cationic antimicrobial peptides are a structurally diverse group of molecules that are found in virtually all eukaryotes examined to date (Hancock et al ., 1995; Hancock and Chapple, 1999) . In addition to their proven role in killing a wide variety of potential pathogens including Gram-positive and Gram-negative bacteria, fungi and viruses, they are also multifunctional modulators of innate immunity . They are known to interact with the outer membrane via the self-promoted uptake pathway permitting good activity against Gramnegative bacteria (Hancock et al ., 1995; Hancock and Chapple, 1999) .
As a result of the wide variety of environments in which Pseudomonas exists, it has evolved mechanisms for responding to many different stimuli. This diversity of responsiveness is reflected in the genome sequence, in which 9.4% of ORFs encode regulatory proteins (Stover et al ., 2000) . One major class of regulatory systems found in P. aeruginosa is the two-component regulatory system family. These systems generally involve a cytoplasmic membrane-spanning histidine kinase sensor protein and a cytoplasmic response regulator. Generally, upon engagement of a periplasmic binding site on the sensor kinase by an effector molecule, this protein autophosphorylates at a histidine residue on the cytoplasmic domain and transfers this phosphate to an aspartate residue of the response regulator leading to increased transcription of multiple genes, and/or repression of others (Rodrigue et al ., 2000) . The Pseudomonas genome contains 64 response regulators and 63 histidine kinases as well as 16 atypical kinases (Rodrigue et al ., 2000) . The function of most of these regulatory proteins is undetermined.
In Salmonella , the PhoP-PhoQ two-component regulatory system is a global regulatory system that responds to limiting concentrations of Mg 2 + and other divalent cations to activate virulence, as well as polymyxin B and cationic antimicrobial peptide resistance, by affecting the transcription of more than 40 genes (Gunn et al ., 1998; Heithoff et al ., 1999; . In P. aeruginosa , the PhoP-PhoQ system has been shown to control resistance to aminoglycosides, polymyxin B, and cationic antimicrobial peptides (Macfarlane et al ., 1999; Macfarlane et al ., 2000; Groisman, 2001) . Insertional inactivation of PhoQ, but not PhoP, also decreases the virulence of P. aeruginosa in a burned mouse model by 100-fold relative to a wild-type parent strain (Brinkman et al ., 2001) . Lipopolysaccharide isolated from the sputum isolates of patients with cystic fibrosis chronically infected with P. aeruginosa showed modifications that reflect those observed in Salmonella when grown in Mg 2 + limiting conditions (Ernst et al ., 1999) .
In Salmonella , PhoP-PhoQ-mediated resistance to polymyxin B and cationic antimicrobial peptides largely occurs through changes in the structure of Lipid A, including the addition of N 4 -aminoarabinose, ethanolamine, and palmitic acid (Zhou et al ., 2001) , decreasing self-promoted uptake across the outer membrane. The addition of aminoarabinose to the Lipid A-phosphates of LPS is catalysed by the seven-gene operon, pmrHFIJKLM (Trent et al ., 2001a, b) which is controlled indirectly by PhoP-PhoQ via another two-component regulatory system, PmrA-PmrB . In addition to this regulatory hierarchy between the two response regulators, Salmonella PmrB can be independently activated by high (100 m M) concentrations of Fe 3 + or by reduced pH (possibly by influencing Fe 3 + solubility) Wosten et al ., 2000) . Homologues of the pmrHFIJKLM LPS modification system (PA3552-PA3558) are present in the genome of P. aeruginosa. In Pseudomonas , the operon contains an eighth gene (PA3559) that is homologous to the ugd gene (UDP-glucose dehydrogenase) that in Salmonella is required for LPS modification and is regulated by the PhoP-PhoQ, PmrA-PmrB and the YojN-RcsA-RcsB systems (Mouslim and Groisman, 2003) .
Pseudomonas aeruginosa possesses several closely related homologues of the response regulator PmrA, but not the signal sensor kinase, PmrB. The most closely related Pseudomonas homologues of the PmrB sensor kinase share similarity only in the C-terminal kinase domain and, to date, the identity of PmrA and PmrB in P. aeruginosa has not been determined.
We present here data that identifies the PmrA-PmrB encoding operon and shows that certain cationic antimicrobial peptides and the polymyxins are capable of inducing the pmrA-pmrB genes, and the putative LPS modification operon, thus increasing the resistance of Pseudomonas to these agents. This argues that the development of cationic peptide derivatives that do not induce these genes will represent an important improvement in therapeutic treatment of Pseudomonas infections of cystic fibrosis patients. We also show that Mg 2 + regulates the LPS modification operon via a mechanism that is dependent upon both PmrA-PmrB and PhoP-PhoQ systems. These and other observations, demonstrate that the PmrA-PmrB and PhoP-PhoQ systems, although sharing several features, operate differently in Pseudomonas and Salmonella .
Results

Identification of pmrA-pmrB
To permit screening for Mg 2 + responsive promoters, a library of mini-Tn 5 luxCDABE mutants was constructed. Strain H974 contained a transposon insertion between ORFs PA4773 and PA4774 and luminescence was strongly activated under Mg 2 + -limitation ( Fig. 1A ; Table 1 ). These open reading frames are situated in an operon upstream of a two-component regulatory system PA4776 (response regulator) and PA4777 (sensor kinase) and a MerR-type regulator, PA4778. The sensor kinase and response regulator pair exhibited significant similarity at the amino acid level to the PmrA-PmrB system of Salmonella (PmrA: 45% identical, 60% similarity; PmrB: 27% identical, 48% similarity), although the periplasmic sensing domain of the sensor protein shared very little homology with that of PmrB from Salmonella and this sensor protein was not the closest homologue of Salmonella PmrB in the P. aeruginosa genome (data not shown).
Regulation of pmrA-pmrB by Mg 2 + As shown in Table 1 , the PA4773:: lux fusion in strain H974 was strongly induced by low (20 m M) Mg 2 + and repressed by high (2 mM) Mg 2 + . To determine if the Mg 2 + -regulation observed for this fusion was controlled by the PhoP-PhoQ system or other Mg 2 + responsive elements, a series of double mutants were created. Because PhoQ-null mutants are known to express PhoP-activated genes under normally repressing conditions (Macfarlane et al ., 1999) , phoQ mutants were constructed in strain H974, producing strain H975 ( phoQ::xylE -Gm R ; PA4773:: lux ). This strain exhibited increased activation of the luxCDABE cassette under high Mg 2 + conditions, suggesting that the luxCDABE fusion in this strain was controlled in part by phoQ (Table 1, Fig. 2 ), although some level of Mg 2 + regulation was still observed. A phoP mutant was also created in the H974 background. This strain (H980) showed wildtype response to Mg 2 + indicating that the effect of phoQ deletion was not mediated via PhoP (Fig. 2 ).
An interposon mutant, H970, was created in the putative pmrB sensor kinase gene by cloning the pmrA-pmrB genes and interrupting the pmrB gene with a cassette containing the reporter gene xylE before recombining the pmrB::xylE -Gm R gene back into P. aeruginosa . The presence of the xylE cassette allowed examination of the response of pmrB transcription to changing environmental conditions. Initial examination of this response showed very little activity regardless of Mg 2 + concentration, with only 6.4 ± 0.4 pmols·mg 2+ . This demonstrates that a functional copy of pmrB is required for maximal expression of pmrB.
To further confirm the strict requirement for pmrB, strain H976 was constructed, in which pmrB was interrupted by the xylE::Gm R cassette in a H974 (PA4773::lux) background. Strain H976 exhibited 10 to 16-fold lower expres- a. Indicates the fold-change of H975 compared to H974. b. Indicates the fold-change of H976 compared to H974. c. The modest 2.5-5.5 fold decrease in RLU in the pmrA-overexpressing strain H976 compared to the same strain with no plasmid or the phoPoverexpressing strain H976 may be due to the overexpression of PmrA in the absence of phosphorylation by PmrB, causing this PmrA to act as a repressor.
sion of the luxCDABE reporter (Table 1 and Fig. 2 ) compared to H974. However both H974 and H976 were inducible in low Mg 2+ concentrations, which is probably a result of PhoQ-mediated regulation of PmrA phosphorylation as discussed below. Strain H981, a pmrA mutant also showed abrogation of the induction of the PA4773:lux fusion under low Mg 2+ conditions (Fig. 2 ). When pmrA was supplied on a plasmid (pUCpmrA) to strain H974 (PA4773::lux), luminescence was increased threefold in low Mg 2+ media (Table 1) . When pUCpmrA was added to strain H976, which lacked a functional copy of pmrB, very little expression was observed from the PA4773::lux fusion, even in low Mg 2+ media. These results are consistent with the hypothesis that PmrB was required to activate PmrA, leading to increased expression of the PA4773::lux fusion. Addition of pUCphoP did not have any effect on expression of the PA4773::lux fusion (Table 1 ).
The pmrA-pmrB genes regulate resistance to polymyxin B and cationic antimicrobial peptides Strains H103 (wt), H970 (pmrB::xylE-Gm R ), and H974 (PA4773::lux) were examined for sensitivity to killing by 2 mg ml -1 polymyxin B after growth in medium containing high (2 mM) or low (20 mM) Mg 2+ (Fig. 3 ). Under high Mg 2+ conditions, all strains exhibited complete susceptibility to polymyxin B, with 6 log orders of killing taking place within 2 min. In low Mg 2+ medium, the parent strain was more resistant to polymyxin B, exhibiting only two-log orders of killing in 10 min, whereas the mutants, H970 and H974 were completely susceptible to killing (i.e.>6 log orders reduction in colonies within 5 min) upon exposure to this concentration of antibiotic. Minimum inhibitory concentration (MIC) data also confirmed the increased susceptibility of strains H970 (pmrB::xylE), H974 (PA4773::lux), and H988 (pmrA::xylE) to polymyxin B, and certain cationic antimicrobial peptides ( Table 2 ). The mutant strains showed eight to 32- fold lower MICs to polymyxin B. Strains H974 (PA4773::lux), H970 (pmrB::xylE), and H988 (pmrA::xylE) showed marginal MIC changes to peptides LL-37, polyphemusin, linear polyphemusin and polymyxin B nonapeptide. Linear polyphemusin and CP208 showed no antimicrobial activity toward any of the strains at the concentrations examined. Strain H974 showed eightfold decreases in MIC to indolicidin, CP11CN and cycCP11CN, whereas strains H970 and H988 showed no significant change in MIC to these compounds. CP10A exhibited a 16-fold reduced MIC to all mutant strains. There was little effect of these mutations on the susceptibility of the strains to amikacin and tobramycin. Thus, strain H974 was generally more sensitive than H970 (pmrB::xylE-Gm R ) or H988 (pmrA::xylE-Gm R ) to most of the antimicrobial agents examined. This may be a result of a polar effect of the transposon on the downstream genes PA4774 and PA4775. The functions of the PA4773, PA4774, and PA4775 genes are unknown, but they share some similarity with polyamine biosynthetic genes.
Induction of the pmrA-pmrB containing operon by polymyxin B and cationic antimicrobial peptides
Two types of antibiotic resistance that can influence clinical outcome are mutational resistance and adaptative resistance. Adaptive antibiotic resistance can involve multiple mechanisms, one of which could involve preexposure to antibiotic. In the case of polymyxin B resistance in Salmonella sp., detection of low Mg 2+ by PhoQ or high Fe 3+ /low pH by PmrB leads to induction of genes responsible for the LPS modifications that reduce selfpromoted uptake across the outer membrane. We utilized the reporter gene fusions in strains H973 and H974 to determine whether or not these signals and/or polymyxin B and cationic antimicrobial peptides could induce expression of pmrB::xylE or PA4773::luxCDABE.
No induction was observed in response to increased Fe 3+ concentrations or lowered pH, the signals responsible for activation of PmrB in Salmonella (Fig. 4A ). However, a dose-dependent induction of pmrB::xylE in the merodiploid strain H973 was observed over a range of concentrations from 0 to 750 ng ml -1 of polymyxin B (Fig. 4B) . Similarly, growth of the pmrB::xylE fusion in high (2 mM) Mg 2+ with the addition of various subinhibitory concentrations of cationic antimicrobial peptides led to a very strong induction of the pmrB::xylE fusion in response to certain cationic peptides (Fig. 4A) . Cattle indolicidin caused a 50-fold increase in expression whereas CP11CN, an improved indolicidin variant, increased expression of the fusion by 45-fold. Polyphemusin was considerably less effective with only a fourfold increase.
Utilization as a reporter of the lux fusion in H974 permitted rapid and sensitive analysis of the effects on the pmrA-pmrB operon of a variety of peptides at different concentrations (Table 3 ). The patterns observed using the lux reporter matched very closely to those observed using the xylE reporter although the fold-changes for induction appeared to be higher when measured by lux expression, probably because baseline expression could be more reliably determined by luminescence. Thus, both of these reporters appeared to be regulated in the same manner. The PA4773::lux fusion in H974 was strongly induced in high Mg 2+ by indolicidin and the indolicidin variants CP10A, cycCP11 and especially CP11CN (Table 3) . These structurally related peptides appeared to affect the expression to similar degrees and importantly, very low ; <1% of MIC) still caused significant induction of this fusion.
The a-helical peptide CEMA was also capable of causing modest induction of luminescence in the PA4773::lux fusion, although the lowest concentration causing induction was significantly higher (0.5 mg ml -1 ) than that observed for CP11CN (31 ng ml -1 ), despite the fact that the MIC of CEMA toward P. aeruginosa is 16-fold lower than that for CP11CN (Table 2) . Conversely, the inactive a-helical variant, CP208 still caused induction of the fusion at extremely high concentrations, but induction fell off rapidly as the concentration of CP208 fell below 8 mg ml -1 . The weakly antimicrobial human cathelicidin peptide LL-37 demonstrated similar effects to CP208. Nevertheless it is clear that induction of this operon was not related to the ability of the peptides to kill bacteria.
Horseshoe crab polyphemusin and related peptides were also examined for their ability to induce luminescence in the PA4773::lux fusion, since polyphemusin displays strong antibacterial activity toward Pseudomonas. Interestingly, the b-hairpin peptide polyphemusin induced only a 17-fold increase in luminescence in the PA4773::lux fusion in H974 (Table 3) , despite the fact that P. aeruginosa is >32 fold more sensitive to killing by this peptide compared to indolicidin and its derivatives (Table 2) . Interestingly, the inactive (with respect to killing) linear polyphemusin variant P1L caused very high induction of the fusion at concentrations from 0.5 to 4 mg ml -1 , equivalent to that observed with the indolicidin-like peptides.
The response to a number of aminoglycoside antibiotics and polymyxins was also examined. None of the aminoglycosides studied were able to induce luminescence in the PA4773::lux fusion strain. Five to 11-fold induction was observed in response to polymyxin B concentrations between 0.125 and 1 mg ml -1 , to colistin (polymyxin E) between 0.25 and 2 mg ml , and polymyxin B nonapeptide between 0.5 and 2 mg ml -1 . Thus, induction by polymyxins was substantially lower that that observed with certain peptides. Fig. 4 . A. Induction of pmrB::xylE fusion in strain H970 by various stimuli. Control -BM2 medium supplemented with 2 mM Mg 2+ pH 7.0; Fe 2+ -addition of 100 mM FeSO 4 + 300 mM desferroximine mesylate; Fe 3+ -addition of 100 mM FeCl 3 + 300 mM 2, 2 dipyridyl; pH 5.8 -altering the pH of BM2 medium to pH 5.8; PM1 -addition of 62 ng ml -1 polyphemusin; Indol. -addition of 500 ng ml -1 indolicidin; CP11 -addition of 500 ng ml -1 CP11CN. B. Dose-dependent response to increasing concentration of polymyxin B of the pmrB::xylE fusion in strain H970. A series of mutants were created in strain H974 to determine whether or not the induction, by peptides, of the PA4773:lux fusion depended upon the products of the phoP, phoQ, pmrA, or pmrB genes. Interestingly, the fusion showed strong induction by CP11CN in all of these strains (Fig. 2) , implying that an unknown regulator may be playing a role in the peptide-mediated activation of this operon.
Induction of putative LPS modification operon (PA3552-PA3559) by cationic antimicrobial peptides
Lipopolysaccharide modifications in Salmonella are directly regulated by PmrA and PmrB. In order to determine how the eight-gene operon encoding the putative LPS modification system (PA3552-PA3559) of Pseudomonas is regulated, we created a plasmid-encoded promoter fusion to the entire intergenic region between PA3551 and PA3552. This pPA3552::lux fusion was then mobilized into strains H103 (WT), H851 (phoP), H854 (phoQ), H988 (pmrA), and H970 (pmrB) and the luminescence of these strains under varying Mg 2+ and peptide conditions was examined. As shown in Fig. 5 , the expression of this fusion was induced 86-fold in low Mg 2+ . Expression was reduced 13-fold in strain H851 (phoP) whereas in strain H988 (pmrA) expression was reduced by twofold, indicating that the PhoP activator is the most important determinant of low Mg 2+ induced activation of the fusion. In high Mg 2+ , the pPA3552::lux fusion in the phoQ mutant was strongly derepressed, similar to the phenotype observed for the PA4773::lux fusion in strain H976 (Fig. 2) and for OprH expression (Macfarlane et al., 1999) . In addition to this regulation by Mg 2+ , the pPA3552::lux fusion was also induced 50 to 80-fold by 4 mg ml -1 CP11CN in all strains examined (Fig. 5) The results obtained using plasmid encoded fusions were then confirmed by carrying out real-time PCR experiments using RNA isolated from H103, H851, and H988, grown in high Mg 2+ , low Mg 2+ and high Mg 2+ + 4 mg ml -1 CP11CN. The results were consistent with the observations made for the plasmid encoded pPA3552::lux fusion (data not shown).
Discussion
Previous work has demonstrated that the PhoP-PhoQ system of P. aeruginosa plays a role in regulating resistance to polymyxin B, a-helical peptides, and aminoglycosides (Ernst et al., 1999; Macfarlane et al., 1999; and hinted at the possibility that other regulatory systems are likely involved in regulation of these phenotypes. We have shown here an additional role for PmrAB. This is conceptually similar to the situation for Salmonella but this study illustrates several key differences between the PhoP-PhoQ and PmrA-PmrB systems of Pseudomonas compared to those of Salmonella (Table 4 ). In Salmonella, the PhoP-PhoQ system responds to decreased Mg 2+ concentrations that are found within the Salmonella- , or 2 mM Mg 2+ with 4 mg ml -1 CP11CN in H103 (wt), H851 (phoP), H854 (phoQ), H988 (pmrA) and H970 (pmrB). The pPA3552::lux fusion contained a lux cassette fused to the entire intergenic region between PA3551 and PA3552 and reports on the transcription of the eight-gene operon encoding the putative LPS modification system (PA3552-PA3559) of Pseudomonas. In Salmonella this operon is PmrA-PmrB regulated.
containing vacuole (SCV) and is essential for intramacrophage survival (Groisman, 2001 ). The PmrA-PmrB system of Salmonella is interconnected with PhoP-PhoQ, but also independently activated by increased concentrations of Fe 3+ Wosten et al., 2000) . The concentration of iron in the mouse stomach and small intestine may approach the levels required for PmrB-signalling . Thus, the Salmonella PhoP-PhoQ and PmrA-PmrB systems appear to be involved in adapting to the many environments encountered during the lifestyle of Salmonella species.
Pseudomonas aeruginosa however, is primarily a pathogen of mucosal surfaces. As such, it does not usually encounter decreases in pH, nor, generally speaking, are the Mg 2+ concentrations within the airway surface fluid, which can be as high as 2.2 mM, limiting (Cowley et al., 1997; Baconnais et al., 1999) The airway surface fluid of CF patients can possess a very high concentration of cationic peptides and proteins (300 mg ml -1 ) (Soong et al., 1997) , yet the lungs of CF patients are often chronically infected with P. aeruginosa, which is capable of resisting these high concentrations of peptides. A previous report indicated that P. aeruginosa from the lungs of patients with cystic fibrosis had LPS modifications similar to those associated with the Salmonella PhoP-PhoQ-regulated changes and this was taken as evidence of activation of PhoP-PhoQ (Ernst et al., 1999) . The data presented here provide an alternative explanation for these modifications as endogenous lung peptides and/or polymyxin E aerosol therapy could have resulted in direct activation of the LPS modification operon and the pmrA-pmrB operon. In vitro data demonstrates that LL-37, a peptide constitutively expressed in the human lung, is capable of inducing the pmrA-pmrB fusion at concentrations in the range of 2-16 mg ml In this paper we have described the identification of a two-component regulatory system, PmrA-PmrB, in P. aeruginosa and shown that Mg 2+ regulates this system. This Mg 2+ regulation is largely independent of the PhoPPhoQ system, which also responds to Mg 2+ . PmrA and PmrB are required for high-level expression of this operon under Mg 2+ -deficient conditions (Fig. 2) . The promoter for the pmrA-pmrB operon contained an imperfect direct repeat that may form a binding site for PmrA (Fig. 6) . Moreover, the fact that the PA4773::lux fusion is expressed despite a polar insertion indicates that there must be a second promoter in front of the downstream pmrA-pmrB genes.
Interestingly, overexpression of phoP in strain H974 (PA4773::lux), H975 (PA4773::lux; phoQ::xylE) and H976 (PA4773::lux; phoP::xylE) did not affect induction of the operon by low Mg 2+ (Table 1) . In contrast PhoQ is capable of affecting operon expression because a phoQ interposon mutant (H975) leads to fivefold increased expression of a PA4773::luxCDABE fusion (Table 1) . This is consistent with the suggestion that in addition to the ability of PhoQ to act as both a kinase and phosphatase toward PhoP (Macfarlane et al., 1999) , it may also be able to act as a phosphatase toward PmrA.
As mentioned above, certain classes of cationic antimicrobial peptides and polymyxin B were shown to activate the system in a Mg 2+ -independent manner. The activation of the PA4773::lux fusion by peptides appears to take place in the absence of both the PhoP-PhoQ system and the PmrA-PmrB system. This suggests that another reg- , 48% similar to Salmonella PmrB in the C-terminal sequence, no similarity in the N-terminal 170 residues ulatory system that responds to peptides exists for this operon. The relationship between inducibility of the system and resistance to a given peptide was incomplete because it did not require peptide activity per se to induce the operon, and because the peptides used have different structures and mechanisms of action and are apparently differentially affected by the PmrAB-regulated resistance mechanism. Indeed, examination of the data in Tables 2  and 3 shows that when the antibacterial activity of an antibiotic was high (e.g. polyphemusin I, CEMA, polymyxin B) its ability to induce PmrA-PmrB was relatively weak. The converse did not hold true, indicating that there can be other reasons for weak antibacterial activity, but the generally poor activity of the indolicidins against P. aeruginosa might be explained in part by their strong ability to induce PmrA-PmrB. Another clear caveat is that the ability to induce the pmrA-pmrB operon is not related to the mechanism of action of specific peptides, as completely non-lethal peptides like CP208 and polymyxin B nonapeptide were able to induce this operon. Similarly there was no strong relationship between peptide structure and the ability to induce the pmrA-pmrB-containing operon as all cationic peptides, including lipopeptides, ahelical, cyclic, and b-hairpin molecules had some ability to induce.
Adaptive antibiotic resistance can involve multiple mechanisms one of which would involve pre-exposure to antibiotic. P. aeruginosa exhibits a phenotype known as adaptive polymyxin B resistance (Gilleland and Farley, 1982) . This phenotype occurs when P. aeruginosa is passaged in medium containing serially increasing concentrations of polymyxin B, after which growth can be observed at concentrations 1000 times greater than the MIC. However, the resistance is not stable, so that when these cells are grown in medium containing no antibiotic, the cells revert to normal susceptibility. The mechanism by which this takes place is unknown, although the regulation of this type of resistance suggests that the cells may be responding directly to the presence of polymyxin B, thereby inducing resistance. The activation of the pmrA-pmrB and the PA3552-PA3559 operons by cationic peptides is consistent with the adaptive polymyxin B resistance phenotype.
In Salmonella, the PmrA-PmrB system directly controls the pmrHFIJKLM system, which is responsible for LPS modifications involved in resistance to cationic antimicrobial peptides. As Pseudomonas possesses orthologues of this system, we examined the regulation of these genes (PA3552-PA3559). The pPA3552:lux fusion was activated by growth on low (20 mM) Mg 2+ . Deletion of either phoP or phoQ resulted in ~95% less expression under low Mg 2+ conditions, whereas deletion of pmrA or pmrB resulted iñ 50% less expression than wild-type cells, but still substantially more than in the phoP or phoQ mutants. Under high Mg 2+ , this fusion was 700-fold derepressed in the phoQ mutant. This is consistent with the promoter structure of PA3552, which contains three binding motifs, two that resemble a PhoP-like binding sequence (Macfarlane et al., 1999) , and one that resembles a putative PmrA-like binding sequence (Fig. 6) .
Previous studies in Pseudomonas have shown that whereas deletion of phoQ results in resistance to cationic antimicrobial peptides under Mg 2+ -replete conditions where the bacteria would normally be sensitive, phoP mutants had no susceptibility phenotype (Macfarlane et al., 1999; . Data presented in this paper suggests that in addition to PhoQ acting as a kinase under low Mg 2+ growth conditions, it also acts as a phosphatase under Fig. 6 . Alignment of the promoter regions of P. aeruginosa oprH, PA4773 and PA3552 depicting putative PhoP and PmrA binding sites (boxed regions). The PhoP binding site (solid line) contains two 6 bp direct repeats separated by a 5-bp spacer region which resembles the known E. coli PhoP binding site (Yamamoto et al., 2002) and that identified in Macfarlane et al. (Macfarlane et al., 1999) . The PmrA binding site (dashed line) contains similar but distinct, direct repeats with a 5-bp spacer region that resembles the Salmonella PmrA binding site (Aguirre et al., 2000) . The distance between the predicted binding sites and the start codon (ATG) is indicated.
Mg
2+ -replete conditions. This difference is consistent with the observation that the PhoQ sensing domain of P. aeruginosa undergoes a large conformational shift when Mg 2+ is non-limiting, while the sensing domain of E. coli PhoQ does not (Lesley and Waldburger, 2001) . Intriguingly, the data also suggest that PhoQ exerts an effect on genes regulated by PmrA exclusively, since phoQ mutants exhibit derepression of a PA4773::lux fusion (Fig. 2) . We have not eliminated the possibility that PhoQ acts via a PmrD-like intermediate, however, unlike the situation observed in Salmonella , the derepression/activation is not dependent upon PhoP (Fig. 2) and there is no gene homologous to pmrD in P. aeruginosa. Thus, although there are many similarities between the PhoP-PhoQ and PmrA-PmrB systems of Pseudomonas and Salmonella, there are many differences as well (Table 4) .
Collectively, these data indicate that the regulation of cationic peptide resistance is very complex. The data indicate P. aeruginosa possesses at least two regulatory systems that respond independently to Mg 2+ , and PmrB appears to also respond to signals other than limiting Mg 2+ and different from those signals that Salmonella PmrB respond to. Clearly, more work is needed to elucidate the mechanism for cationic peptide-mediated gene induction. Although, the data presented here suggest a potential problem with induced resistance to cationic peptides, the results also point to one group of peptides, the polyphemusins, that are almost unaffected by PmrA-PmrBmediated resistance and have a relatively poor ability to induce the pmrA-pmrB operon. Thus, this provides clear evidence that it is possible to design cationic antimicrobial peptides which are unaffected by the resistance mechanisms discussed here. Future peptide design efforts will be directed towards exploiting this observation.
Experimental procedures
Bacterial strains, primers and growth conditions
The bacterial strains and plasmids used in this study are described in Table 5 . The sequences of DNA primers used in the study are available by request from the authors. Cultures were routinely grown in Luria-Bertani broth or BM2-glucose minimal medium containing low (20 mM) or high (2 mM) MgSO 4 concentrations. Antibiotics for selection were used at the following concentrations: tetracycline, 100 mg ml -1 for P. aeruginosa and 10 mg ml -1 for E. coli; ampicillin 100 mg ml
for E. coli; carbenicillin, 300-500 mg ml -1 for P. aeruginosa; gentamicin 50 mg ml -1 for P. aeruginosa and 15 mg ml -1 for E. coli. Routine genetic manipulations were carried out according to Maniatis et al. (1989) .
DNA manipulations
A bank of luxCDABE fusion strains were made by mobilizing pUT mini-Tn5 luxCDABE (Winson et al., 1998) into H103 and selecting for resistance to 100 mg ml -1 tetracycline. Resulting mutants were screened for differential expression of the fusion in response to high (2 mM) or low (20 mM) MgSO 4 concentrations. Interrupted genes were identified by arbitrarily primed PCR using primers Tn5luxout (5¢-GTCAT TCAATATTGGCAGGTAAACACTATTATCACC-3¢) and ARB1 (5¢-GGCCACGCGTCGACTAGTACNNNNNGATAT-3¢) and the following cycling conditions: 95∞C for 5 min followed by 5 cycles of 95∞C for 30 s, 45∞C for 30 s, and 72∞C for 1.5 min. Thirty cycles were then performed with cycling at 95∞C for 30 s, 60∞C for 30 s, and 72∞C for 2 min followed by an extension step at 72∞C for 5 min. The products from this PCR reaction were then used as the template in another PCR reaction using primers ARB2 (GGCCACGCGTCGACTAG TAC) and Tn5luxout. The cycling conditions for this second reaction were 95∞C for 5 min followed by 30 cycles of 95∞C for 30 s, 60∞C for 30 s, and 72∞C for 1.5 min followed by an extension step at 72∞C for 5 min. All PCR reactions used 150 mM each dNTP, 5% DMSO, 1 ¥ polymerase buffer and 0.5 mM each primer with 1.25 U of Vent polymerase (NEB, Mississauga, Canada). These amplicons were then sequenced using BigDye sequencing chemistry (PE Biosystems, Foster City, CA) on a BaseStation51 DNA fragment analyzer (MJ Research, Reno, NV). Strain H974 was identified as having an insertion in the intergenic region between PA4773 and PA4774 and is described hereafter as a PA4773::lux mutant.
For construction of a pmrB interposon mutant, a fragment containing the pmrA and pmrB genes was PCR amplified using primers designed from the genome sequence. These amplicons were then cloned into pCR2.1-TOPO using the TOPO-TA cloning kit (Invitrogen, Carlsbad CA) according to the manufacturer's instructions. An EcoRI fragment containing the pmrA-pmrB genes was then ligated into EcoRI digested pEX18Tc (Hoang et al., 1998) creating pEXpmrAB. A BamHI fragment from pX1918GT containing a xylE-Gm R cassette was cloned into the unique BglII site in the pmrB gene of pEXpmrAB creating pEXpmrB-xylE. The inserted cassette was shown to be in the forward orientation by restriction analysis. For construction of strain H973, a pmrB merodiploid, pEXpmrB-xylE was mobilized into the chromosome without selection on 5% sucrose to maintain the plasmid vector sequence. To produce the pmrA interposon mutant, pmrA was PCR amplified and cloned into pEX100T (Schweizer and Hoang, 1995) producing pEXpmrA. A xylEGm R cassette from plasmid pX1918GT was removed with PstI and ligated into PstI digested pEXpmrA. Gene-replacement constructs were mobilized into P. aeruginosa H103 using biparental mating and resolved by successive selection on 50 mg ml -1 gentamicin and 5% sucrose. The allelic exchanges were confirmed by PCR. The PCR amplified pmrA gene was cloned into pUCP23, producing pUCpmrA.
Plasmid pUCPlux was created by first replacing the MCS of pUCP23 (West et al., 1994) with a new linker (EcoRIBamHI-SmaI-XhoI-NotI-HindIII) . The luxCDABE genes from plasmid pCS26 (M. Surette) were cloned as a NotI fragment into the new MCS. The orientation of the luxCDABE cassette was confirmed by restriction digestion. To determine how the eight-gene operon encoding the putative LPS modification system (PA3552-PA3559) of Pseudomonas is regulated, a plasmid-encoded promoter fusion to the entire intergenic region between PA3551 and PA3552 was created by PCR amplifying the promoter for PA3552 and cloning it in front of the luxCDABE cassette, to produce pUCPlux-p PA3552 .
Real-time PCR assays
Total RNA was isolated from mid-log P. aeruginosa grown in BM2-glucose minimal media with 20 mM Mg 2+ , 2 mM Mg 2+ , or 2 mM Mg 2+ and 4 mg ml -1 CP11CN using RNeasy mini columns (Qiagen). Four micrograms of total RNA was combined with 0.5mM dNTPs, 500 U ml -1 SuperaseIN (Ambion), 10 mM DTT, in 1¥ reaction buffer and reverse transcribed for 1 h at 37∞C and 2 h at 42∞C with 10 000 U ml -1 Superscript II reverse transcriptase (Invitrogen). The RNA was destroyed by the addition of 170 mM NaOH and incubation at 65∞C for 10 min. The reaction was neutralized by addition of HCl. The cDNA was then used as template for real-time PCR using SYBR Green PCR Master Mix (Applied Biosystems) in an ABI Prism 7000 (Applied Biosystems, Foster City, CA). The real-time PCR was carried out in 1 ¥ SYBR Green Master Mix, with 200 nM forward and reverse primers designed to the PA3552 ORF, and 1 ml cDNA. All reactions were normalized to the rpsL gene encoding the 30S ribosomal protein S12.
Gene reporter assays
XylE assays were performed as described previously (Macfarlane et al., 1999) . Briefly, a 25 ml P. aeruginosa culture was grown in 125 ml Erlenmeyer flasks to an OD 600 of 0.3-0.6. The cells were pelleted by centrifugation, resuspended in 750 ml of 50 mM potassium phosphate buffer pH 7.5 containing 10% v/v acetone, and broken by sonication. Unbroken cells and debris were removed by centrifugation. The protein content of the crude extracts was determined by the modified Lowry assay. Aliquots of the cell extracts were then added to 1 ml of 50 mM potassium phosphate buffer, pH 7.5 containing 0.3 mM catechol. The absorbance change of the solution was monitored at 375 nm and the rate of change was used to determine the enzyme activity in the sample using an E375 for 2-hydroxymuconic semialdehyde of 44 000.
Induction of the luxCDABE fusion in liquid media was measured using a SPECTRAFluorPlus luminometer (Tecan, San Jose, CA). Luminescence was corrected for growth by simultaneously monitoring the absorbance at 620 nm. Image analysis of colonies grown on agar plates was performed with a Luminograph LB980 photon-imaging video system (EG and G Berthold, Bundoora, Australia).
Killing curves
Pseudomonas aeruginosa cultures were grown to OD 600 of 0.3-0.6 in BM2-glucose minimal media containing 20 mM Mg
2+
. These cultures were then diluted 1:100 into prewarmed sodium phosphate buffer, pH 7.5 containing 2 mg ml -1 polymyxin B sulphate (Sigma). Samples were shaken at 37∞C and aliquots were withdrawn at specified times, and then assayed for survivors by plating onto LB agar.
Minimal inhibitory concentrations (MICs)
Minimal inhibitory concentrations were assessed using standard broth microdilution procedures in BM2 glucose minimal medium containing 10 mM or 2 mM Mg 2+ (Macfarlane et al., 1999) . Growth was scored following 24 h incubation at 37∞C. For measuring MICs against cationic antimicrobial peptides, a modified assay was used to prevent artificially high MICs due to aggregation of peptides and binding to polystyrene (Zhang et al., 2000) .
